Blincyto OK Now in Hand, Amgen Astellas JV Revs Up for Foray into Japan Oncology Market

Steve Sugino, President & Representative Director, Amgen Astellas BioPharma Amgen Astellas Biopharma (AABP), a Japanese joint venture of the two namesake companies, is set to make inroads into the Japan oncology market as early as November with its leukemia drug...read more